Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Shen

Showing results (1441-1450 of 1,553) with videos related to

Pageof 156
Sort By:
Eclinicalmedicine|July 21, 2025
Efficacy and safety of narlumosbart, an anti-RANKL monoclonal antibody, in postmenopausal women with osteoporosis: a multi-center, randomized, double-blind, placebo- and active-controlled, phased II studyYue Chi, Yukun Li, Qun Cheng, et al.
Cancer Letters|July 17, 2025
Multimodal radiopathomics signature for prediction of response to immunotherapy-based combination therapy in gastric cancer using interpretable machine learningWeicai Huang, Xiaoyan Wang, Rou Zhong, et al.
Chinese Journal of Cancer|January 16, 2016
Expert consensus on maintenance treatment for metastatic colorectal cancer in ChinaRui-Hua Xu, Lin Shen, Jin Li, et al.
Plos One|September 30, 2020
Development and external validation of a prediction risk model for short-term mortality among hospitalized U.S. COVID-19 patients: A proposal for the COVID-AID risk toolKaveh Hajifathalian, Reem Z Sharaiha, Sonal Kumar, et al.
BMC Medicine|October 25, 2022
Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trialDan Liu, Jun Zhou, Yongsheng Wang, et al.
The Oncologist|April 21, 2022
Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: 
Safety, Efficacy, and BiomarkersYakun Wang, Tianshu Liu, Gongyan Chen, et al.
Nature Medicine|June 3, 2024
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final resultsChangsong Qi, Chang Liu, Jifang Gong, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 15, 2026
Updated Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor (2025)Hidekazu Hirano, Yoichi Naito, Tsuyoshi Takahashi, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 29, 2009
[Capecitabine combined with cisplatin as first-line therapy in Chinese patients with advanced gastric carcinoma-a phase II clinical study]Bing Hu, Ji-Ren Yu, Zhao-Zhang Wen, et al.
Nature Communications|February 14, 2023
Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancerWenhao Shi, Yushen Wang, Chen Xu, et al.
Pageof 156

Showing results (1441-1450 of 1,553) with videos related to

Sort By:
Pageof 156
Eclinicalmedicine|July 21, 2025
Efficacy and safety of narlumosbart, an anti-RANKL monoclonal antibody, in postmenopausal women with osteoporosis: a multi-center, randomized, double-blind, placebo- and active-controlled, phased II studyYue Chi, Yukun Li, Qun Cheng, et al.
Cancer Letters|July 17, 2025
Multimodal radiopathomics signature for prediction of response to immunotherapy-based combination therapy in gastric cancer using interpretable machine learningWeicai Huang, Xiaoyan Wang, Rou Zhong, et al.
Chinese Journal of Cancer|January 16, 2016
Expert consensus on maintenance treatment for metastatic colorectal cancer in ChinaRui-Hua Xu, Lin Shen, Jin Li, et al.
Plos One|September 30, 2020
Development and external validation of a prediction risk model for short-term mortality among hospitalized U.S. COVID-19 patients: A proposal for the COVID-AID risk toolKaveh Hajifathalian, Reem Z Sharaiha, Sonal Kumar, et al.
BMC Medicine|October 25, 2022
Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trialDan Liu, Jun Zhou, Yongsheng Wang, et al.
The Oncologist|April 21, 2022
Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: 
Safety, Efficacy, and BiomarkersYakun Wang, Tianshu Liu, Gongyan Chen, et al.
Nature Medicine|June 3, 2024
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final resultsChangsong Qi, Chang Liu, Jifang Gong, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 15, 2026
Updated Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor (2025)Hidekazu Hirano, Yoichi Naito, Tsuyoshi Takahashi, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 29, 2009
[Capecitabine combined with cisplatin as first-line therapy in Chinese patients with advanced gastric carcinoma-a phase II clinical study]Bing Hu, Ji-Ren Yu, Zhao-Zhang Wen, et al.
Nature Communications|February 14, 2023
Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancerWenhao Shi, Yushen Wang, Chen Xu, et al.
Pageof 156